PASG Annual Cash & Cash Equivalents
$21.71 M
-$12.89 M-37.26%
31 December 2023
Summary:
As of January 23, 2025, PASG annual cash & cash equivalents is $21.71 million, with the most recent change of -$12.89 million (-37.26%) on December 31, 2023. During the last 3 years, it has fallen by -$113.29 million (-83.92%). PASG annual cash & cash equivalents is now -86.34% below its all-time high of $158.87 million, reached on December 31, 2019.PASG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PASG Quarterly Cash And Cash Equivalents
$32.29 M
+$7.52 M+30.37%
30 September 2024
Summary:
As of January 23, 2025, PASG quarterly cash and cash equivalents is $32.29 million, with the most recent change of +$7.52 million (+30.37%) on September 30, 2024. Over the past year, it has dropped by -$1.29 million (-3.83%). PASG quarterly cash and cash equivalents is now -91.20% below its all-time high of $366.83 million, reached on March 1, 2020.PASG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PASG Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.3% | -3.8% |
| 3 y3 years | -83.9% | -3.8% |
| 5 y5 years | -12.7% | -3.8% |
PASG Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.2% | at low | -75.0% | +48.8% |
| 5 y | 5-year | -86.3% | at low | -91.2% | +48.8% |
| alltime | all time | -86.3% | at low | -91.2% | +48.8% |
Passage Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $32.29 M(+30.4%) |
| June 2024 | - | $24.77 M(-32.6%) |
| Mar 2024 | - | $36.77 M(+69.4%) |
| Dec 2023 | $21.71 M(-37.3%) | $21.71 M(-35.3%) |
| Sept 2023 | - | $33.58 M(+10.9%) |
| June 2023 | - | $30.29 M(-9.2%) |
| Mar 2023 | - | $33.37 M(-3.6%) |
| Dec 2022 | $34.60 M | $34.60 M(-44.7%) |
| Sept 2022 | - | $62.57 M(-31.3%) |
| June 2022 | - | $91.13 M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $101.61 M(-21.2%) |
| Dec 2021 | $128.97 M(-4.5%) | $128.97 M(-20.8%) |
| Sept 2021 | - | $162.89 M(-24.4%) |
| June 2021 | - | $215.46 M(-13.7%) |
| Mar 2021 | - | $249.52 M(+84.8%) |
| Dec 2020 | $135.00 M(-15.0%) | $135.00 M(-32.7%) |
| Sept 2020 | - | $200.57 M(-43.2%) |
| June 2020 | - | $353.42 M(-3.7%) |
| Mar 2020 | - | $366.83 M(+130.9%) |
| Dec 2019 | $158.87 M(+539.0%) | $158.87 M |
| Dec 2018 | $24.86 M | - |
FAQ
- What is Passage Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Passage Bio?
- What is Passage Bio annual cash & cash equivalents year-on-year change?
- What is Passage Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Passage Bio?
- What is Passage Bio quarterly cash and cash equivalents year-on-year change?
What is Passage Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of PASG is $21.71 M
What is the all time high annual cash & cash equivalents for Passage Bio?
Passage Bio all-time high annual cash & cash equivalents is $158.87 M
What is Passage Bio annual cash & cash equivalents year-on-year change?
Over the past year, PASG annual cash & cash equivalents has changed by -$12.89 M (-37.26%)
What is Passage Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PASG is $32.29 M
What is the all time high quarterly cash and cash equivalents for Passage Bio?
Passage Bio all-time high quarterly cash and cash equivalents is $366.83 M
What is Passage Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, PASG quarterly cash and cash equivalents has changed by -$1.29 M (-3.83%)